Project Grant HT94252510340
Award Date
7/1/25
Completion Date
6/30/27
Dollars Obligated
$2M
Federal Agency
Defense Health Agency
Awardee
IRR Inc. (NMB3LMK1EPC6)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Santa Barbara, CA 93103, USA
Similar Awards
The Department of the Army Medical Command awarded a $2,008,900 project grant to the Veterans Medical Research Foundation of San Diego under the Military Medical Research and Development program (CFDA 12.420). The four-year project grant will fund research into combined nonpharmacological therapies for mild traumatic brain injury (mTBI)-related headaches from September 2021 through August 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical...
The Department of the Army Medical Command awarded a $1,859,430 project grant to the Western Institute For Veterans Research to support early recognition of undiagnosed viral syndromes and their predictors over time. This funding supports the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health through innovative medical research solutions for battlefield injuries. The grant will allow WIVR to deliver research from September 1,...
The Department of the Army Medical Command awarded a $3,246,800 project grant to Duke University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2022 to June 30, 2026 to develop resorbable poly(ester urea) films for sustained delivery of meloxicam and bupivacaine to manage pain in critical combat casualty environments. Through basic, applied, and advanced biomedical research, the Military Medical Research and Development...
IHP Therapeutics Inc. was awarded a $217,928 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from March 2022 through September 2023 to develop a novel glycan therapeutic to treat Acute Respiratory Distress Syndrome. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research solutions. This award...
This federal Project Grant award of $1,991,326.00, awarded by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research at Beth Israel Deaconess Medical Center, Inc. (Bidmc) aimed at suppressing barrier antimicrobial defenses in the context of trauma. The 3-year grant, with a performance period from September 30, 2024 to September 29, 2027, will enable Bidmc, a prominent academic medical center in...
The Department of the Army Medical Command awarded a $157,500 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from June 1, 2021 to May 31, 2022 to restore functional ARF tumor suppression in non-small cell lung carcinoma through the use of peptide mimics. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
The Department of the Army Medical Command awarded a $520,751 Project Grant to the Veteran Research And Education Foundation Of ST Louis through the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from August 1, 2022 to July 31, 2026 to improve outcomes for prostate cancer patients based on comorbidities, with the goal of developing personalized medicine approaches. Through this award, the Foundation will conduct research to investigate medical...
The U.S. Department of the Army Medical Command, through the Military Medical Research and Development (CFDA 12.420) federal grant program, has awarded a $293,500 project grant to The Medical Research, Infrastructure And Health Services Fund Of The Tel Aviv Medical Center. The grant, awarded on April 1, 2025, will support a 2-year research project investigating clinical variations in epidermolysis bullosa, a rare genetic skin condition, with the goal of advancing understanding of wound healing...
The Department of the Army Medical Command awarded a $438,916 project grant to Universitat Bern in Switzerland under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 1, 2022 to August 31, 2026 to target PARP inhibitor resistance. Through this funding, Universitat Bern researchers will investigate medical solutions for targeting resistance to poly (ADP-ribose) polymerase inhibitors, an area of focus under the Military Medical...
The Department of the Army Medical Command awarded a $5,753,844 Project Grant under the Military Medical Research and Development federal grant program (CFDA 12.420) to the Portland VA Research Foundation, Inc. for the period of July 1, 2022 to June 30, 2026. The grant will support the preclinical development of novel liver-stage active antimalarial drugs with radical cure potential. Through innovative research, the goal is to transform healthcare for service members and the public by...